A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
167/206, 167/322
A61K 31/765 (2006.01) A61K 38/16 (2006.01) A61K 38/44 (2006.01) A61K 38/49 (2006.01)
Patent
CA 1297792
"IMPROVED FIBRINOLYTIC COMPOSITION" Abstract of the Invention In accordance with the present invention, a composition is provided that is effective in dissolving blood clots and reestablishing and maintaining blood flow through thrombosed coronary or other blood vessels. The fibrinolytic composition of the present invention comprises an enzyme, such as streptokinase, urokinase, tissue plasminogen activator or other fibrinolytic enzyme, and a surface-active copolymer. The surface-active copolymer can be an ethylene oxide-propylene oxide condensation product with the following general formula: HO(C2H4O)b(C3H6O)a(C2H4O)bH wherein a is an integer such that the hydrophobe represented by (C3H6O) has a molecular weight of approximately 950 to 4000, preferably approximately 1750 to 3500, and b is an integer such that the hydrophile portion represented by (C2H4O) constitutes approximately 50% to 90% by weight of the compound.
537052
Duncan Alexander
Hunter Robert L.
Emory University
Finlayson & Singlehurst
LandOfFree
Fibrinolytic composition does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Fibrinolytic composition, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Fibrinolytic composition will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1297750